1Jemal A,Murray T,Samuels A,et al.Cancer statistics[J].CA Cancer J Clin,2003,53:5-26.
2Botteman MF,Pashos CL,Redaelli A,et al.The health economics of bladder cancer:a comprehensive review of the published literature[J].Pharmacoeconomics,2003,21:1315-1330.
3Brown FM.Urine cytology.Is it still the gold standard for screening[J]? Urol Clin North Am,2000,27:25-37.
4Black PC,Brown GA,Dinney CP.Molecular markers of urothelial cancer and their use in the monitoring of superficial urothelial cancer[J].J Clin Oncol,2006,24:5528-5535.
5Grossman HB,Soloway M,Messing E,et al.Surveillance for recurrentbladder cancer using a point-of-care proteomic assay[J].JAMA,2006,295:299-305.
6Tritschler S,Scharf S,Karl A,et al.Validation of the diagnostic value of NMP221 BladderChek1 test as a marker for bladder cancer by photodynamic diagnosis[J].Eur Urol,2007,51:403-408.
8Eissa S,Kassim SK,Labib RA,et al.Detection of bladder carcinoma by combined testing of urine for hyaluronidase and cytokeratin 20 RNAs[J].Cancer,2005,103:1356-1362.
9Golshani R,Hautmann SH,Estrella V,et al.HAS1 expression in bladder cancer and its relation to urinary HA test[J].Int J Cancer,2007,120:1712-1720.
10Shariat SF,Casella R,Khoddami SM,et al.Urine detection of survivin is a sensitive marker for the noninvasive diagnosis of bladder cancer[J].J Urol,2004,171:626-630.
3Morsi MI,Youssef AI,Hassouna ME,gf al. Telomerase activity,cytokeratin 20 and cytokeratin 19 in urine cells o. bladder cancerpatients[J]. J Egypt Natl Cane Inst,2006,18(1) :82-92.
4Somji S, Cao L, Mehus A,et al. Comparison of expression pat-terns of keratin 6,7,16,17, and 19 within multiple independ-ent isolates of As( + 3)- and Cd ( + 2)-induced bladder cancer:keratin 6, 7,16, 17. and 19 in bladder cancer [J]. Cell BiolToxicol,2011,27(6) :381-396.
5Voutsinas GE, Stravopodis DJ. Molecular targeting and gene deliv- ery in bladder Cancer therapy [J]. J BUON, 2009, 14 Suppl 1 (11 ) : S69-S78.
6Ecke TH. Focus on urinary bladder Cancer markers: a review [J]. Minerva Urol Nefrol, 2008, 60 (4): 237-246.
7Yildirim U, Erdem H, Kayikci A, et al. Cyclooxygenase-2 and survivin in superficial urothelial carcinoma of the bladder and cor- relation with intratumoural microvessel density[J]. J Int Med Res, 2010, 38 (5): 1689-1699.
8Morsi MI, Youssef AI, Hassouna ME, et al. Telomerase activity, cytokeratin 20 and cytokeratin 19 in urine cells of bladder Cancer patients[J]. J Egypt Natl Canc Inst, 2006, 18 (1): 82-92.
9Somji S, Cao L, Mehus A, et al. Comparison of expression pat- terns of keratin 6, 7, 16, 17, and 19 within multiple Indepen- dent isolates of As (+3) - and Cd (+2) -induced bladder Can- cer: keratin 6, 7, 16, 17, and 19 in bladder Cancer [J]. Cell BiolToxicol, 2011, 27 (6): 381-396.
10Chao KL, Muthukumar L, Herzberg O. Structure of human hyaluronidase-1, a hyaluronan hydrolyzing enzyme involved in tu- mor growth and angiogenesis [J]. Biochemistry, 2007, 46 (23) : 6911-6920.
